Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Pfizer, BioNTech initiate rolling submission of BLA for mRNA vaccine approval » 06:47
05/07/21
05/07
06:47
05/07/21
06:47
PFE

Pfizer

$39.19 /

-0.39 (-0.99%)

, BNTX

BioNTech

$168.03 /

-2.65 (-1.55%)

Pfizer (PFE) and BioNTech…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$39.19 /

-0.39 (-0.99%)

BNTX BioNTech
$168.03 /

-2.65 (-1.55%)

PFE Pfizer
$39.19 /

-0.39 (-0.99%)

05/06/21
Fly Intel: Top five analyst downgrades
05/06/21 Mizuho
Pfizer downgraded to Neutral from Buy at Mizuho
05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
05/05/21 Barclays
Pfizer price target raised to $40 from $37 at Barclays
BNTX BioNTech
$168.03 /

-2.65 (-1.55%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
PFE Pfizer
$39.19 /

-0.39 (-0.99%)

  • 23
    Jul
PFE Pfizer
$39.19 /

-0.39 (-0.99%)

PFE Pfizer
$39.19 /

-0.39 (-0.99%)

BNTX BioNTech
$168.03 /

-2.65 (-1.55%)

PFE Pfizer
$39.19 /

-0.39 (-0.99%)

BNTX BioNTech
$168.03 /

-2.65 (-1.55%)

Yesterday
On The Fly
Moderna, Pfizer slip despite stronger results as U.S. backs vaccine IP waiver » 14:30
05/06/21
05/06
14:30
05/06/21
14:30
MRNA

Moderna

$160.79 /

-1.89 (-1.16%)

, PFE

Pfizer

$38.91 /

-0.67 (-1.69%)

, BNTX

BioNTech

$170.34 /

-0.34 (-0.20%)

, AZN

AstraZeneca

$53.14 /

-0.48 (-0.90%)

, JNJ

Johnson & Johnson

$166.93 /

-0.16 (-0.10%)

, NVAX

Novavax

$175.00 /

+3.02 (+1.76%)

, VXRT

Vaxart

$6.88 /

-0.485 (-6.59%)

, CVAC

CureVac

$93.63 /

-7.39 (-7.32%)

While both Moderna (MRNA)…

ShowHide Related Items >><<
VXRT Vaxart
$6.88 /

-0.485 (-6.59%)

PFE Pfizer
$38.91 /

-0.67 (-1.69%)

NVAX Novavax
$175.00 /

+3.02 (+1.76%)

MRNA Moderna
$160.79 /

-1.89 (-1.16%)

JNJ Johnson & Johnson
$166.93 /

-0.16 (-0.10%)

CVAC CureVac
$93.63 /

-7.39 (-7.32%)

BNTX BioNTech
$170.34 /

-0.34 (-0.20%)

AZN AstraZeneca
$53.14 /

-0.48 (-0.90%)

MRNA Moderna
$160.79 /

-1.89 (-1.16%)

05/05/21 Jefferies
Jefferies says COVID vaccine availability a supply-chain issue
05/03/21 Piper Sandler
Piper reiterates $234 target on Moderna after WHO Emergency Use Listing
04/29/21 Piper Sandler
Piper keeps $234 target on Moderna after raised Covid vaccine guidance
04/15/21 Piper Sandler
Moderna price target raised to $234 from $208 at Piper Sandler
PFE Pfizer
$38.91 /

-0.67 (-1.69%)

05/06/21
Fly Intel: Top five analyst downgrades
05/06/21 Mizuho
Pfizer downgraded to Neutral from Buy at Mizuho
05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
05/05/21 Barclays
Pfizer price target raised to $40 from $37 at Barclays
BNTX BioNTech
$170.34 /

-0.34 (-0.20%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
AZN AstraZeneca
$53.14 /

-0.48 (-0.90%)

05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/12/21
Fly Intel: Top five analyst downgrades
JNJ Johnson & Johnson
$166.93 /

-0.16 (-0.10%)

05/05/21 Argus
Emergent BioSolutions downgraded to Hold from Buy at Argus
04/29/21 Wells Fargo
Boston Scientific price target raised to $50 from $42 at Wells Fargo
04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
NVAX Novavax
$175.00 /

+3.02 (+1.76%)

03/26/21 B. Riley
Novavax selloff on 'rumored' production delay overdone, says B. Riley
03/12/21 H.C. Wainwright
Novavax price target raised to $317 from $207 at H.C. Wainwright
VXRT Vaxart
$6.88 /

-0.485 (-6.59%)

03/04/21 B. Riley
Vaxart price target lowered to $13 from $16 at B. Riley Securities
11/18/20 B. Riley
Vaxart price target lowered to $16 from $22 at B. Riley Securities
10/13/20 B. Riley
B. Riley views Vaxart as key player in 'second wave' of Covid vaccines
09/09/20 B. Riley
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
CVAC CureVac
$93.63 /

-7.39 (-7.32%)

04/26/21 Credit Suisse
CureVac assumed with an Underperform at Credit Suisse
04/26/21 Guggenheim
CureVac initiated with a Buy at Guggenheim
01/07/21 Morgan Stanley
CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley
12/10/20 Credit Suisse
CureVac downgraded to Underperform on rising valuation at Credit Suisse
VXRT Vaxart
$6.88 /

-0.485 (-6.59%)

PFE Pfizer
$38.91 /

-0.67 (-1.69%)

NVAX Novavax
$175.00 /

+3.02 (+1.76%)

MRNA Moderna
$160.79 /

-1.89 (-1.16%)

JNJ Johnson & Johnson
$166.93 /

-0.16 (-0.10%)

AZN AstraZeneca
$53.14 /

-0.48 (-0.90%)

  • 28
    Jan
  • 14
    Aug
  • 23
    Jul
  • 19
    May
MRNA Moderna
$160.79 /

-1.89 (-1.16%)

JNJ Johnson & Johnson
$166.93 /

-0.16 (-0.10%)

CVAC CureVac
$93.63 /

-7.39 (-7.32%)

AZN AstraZeneca
$53.14 /

-0.48 (-0.90%)

VXRT Vaxart
$6.88 /

-0.485 (-6.59%)

PFE Pfizer
$38.91 /

-0.67 (-1.69%)

NVAX Novavax
$175.00 /

+3.02 (+1.76%)

MRNA Moderna
$160.79 /

-1.89 (-1.16%)

JNJ Johnson & Johnson
$166.93 /

-0.16 (-0.10%)

CVAC CureVac
$93.63 /

-7.39 (-7.32%)

BNTX BioNTech
$170.34 /

-0.34 (-0.20%)

AZN AstraZeneca
$53.14 /

-0.48 (-0.90%)

VXRT Vaxart
$6.88 /

-0.485 (-6.59%)

PFE Pfizer
$38.91 /

-0.67 (-1.69%)

NVAX Novavax
$175.00 /

+3.02 (+1.76%)

MRNA Moderna
$160.79 /

-1.89 (-1.16%)

JNJ Johnson & Johnson
$166.93 /

-0.16 (-0.10%)

CVAC CureVac
$93.63 /

-7.39 (-7.32%)

BNTX BioNTech
$170.34 /

-0.34 (-0.20%)

AZN AstraZeneca
$53.14 /

-0.48 (-0.90%)

Periodicals
Germany's Merkel opposed to vaccine patent waivers, Bloomberg reports » 12:14
05/06/21
05/06
12:14
05/06/21
12:14
MRNA

Moderna

$156.69 /

-5.99 (-3.68%)

, PFE

Pfizer

$38.89 /

-0.69 (-1.74%)

, BNTX

BioNTech

$164.18 /

-6.5 (-3.81%)

, AZN

AstraZeneca

$53.16 /

-0.46 (-0.86%)

, JNJ

Johnson & Johnson

$166.87 /

-0.22 (-0.13%)

, NVAX

Novavax

$168.55 /

-3.43 (-1.99%)

, CVAC

CureVac

$93.30 /

-7.72 (-7.64%)

, VXRT

Vaxart

$6.60 /

-0.765 (-10.39%)

German Chancellor Angela…

German Chancellor Angela Merkel is opposed to a U.S. proposal to waive patent protections for COVID-19 vaccines, stating that such a plan would create "severe complications" for the production of vaccines, reported Bloomberg, citing a German government spokeswoman. Without a profit incentive, drugmakers might not move as aggressively to make vaccines, the industry has argued. Companies with approved COVID-19 vaccines or working on such vaccines include Pfizer (PFE), BioNTech (BNTX), Moderna (MRNA), AstraZeneca (AZN), Johnson & Johnson (JNJ), Novavax (NVAX), Vaxart (VXRT) and CureVac (CVAC). Reference Link

ShowHide Related Items >><<
VXRT Vaxart
$6.60 /

-0.765 (-10.39%)

PFE Pfizer
$38.89 /

-0.69 (-1.74%)

NVAX Novavax
$168.55 /

-3.43 (-1.99%)

MRNA Moderna
$156.69 /

-5.99 (-3.68%)

JNJ Johnson & Johnson
$166.87 /

-0.22 (-0.13%)

CVAC CureVac
$93.30 /

-7.72 (-7.64%)

BNTX BioNTech
$164.18 /

-6.5 (-3.81%)

AZN AstraZeneca
$53.16 /

-0.46 (-0.86%)

MRNA Moderna
$156.69 /

-5.99 (-3.68%)

05/05/21 Jefferies
Jefferies says COVID vaccine availability a supply-chain issue
05/03/21 Piper Sandler
Piper reiterates $234 target on Moderna after WHO Emergency Use Listing
04/29/21 Piper Sandler
Piper keeps $234 target on Moderna after raised Covid vaccine guidance
04/15/21 Piper Sandler
Moderna price target raised to $234 from $208 at Piper Sandler
PFE Pfizer
$38.89 /

-0.69 (-1.74%)

05/06/21
Fly Intel: Top five analyst downgrades
05/06/21 Mizuho
Pfizer downgraded to Neutral from Buy at Mizuho
05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
05/05/21 Barclays
Pfizer price target raised to $40 from $37 at Barclays
BNTX BioNTech
$164.18 /

-6.5 (-3.81%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
AZN AstraZeneca
$53.16 /

-0.46 (-0.86%)

05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/12/21
Fly Intel: Top five analyst downgrades
JNJ Johnson & Johnson
$166.87 /

-0.22 (-0.13%)

05/05/21 Argus
Emergent BioSolutions downgraded to Hold from Buy at Argus
04/29/21 Wells Fargo
Boston Scientific price target raised to $50 from $42 at Wells Fargo
04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
NVAX Novavax
$168.55 /

-3.43 (-1.99%)

03/26/21 B. Riley
Novavax selloff on 'rumored' production delay overdone, says B. Riley
03/12/21 H.C. Wainwright
Novavax price target raised to $317 from $207 at H.C. Wainwright
CVAC CureVac
$93.30 /

-7.72 (-7.64%)

04/26/21 Credit Suisse
CureVac assumed with an Underperform at Credit Suisse
04/26/21 Guggenheim
CureVac initiated with a Buy at Guggenheim
01/07/21 Morgan Stanley
CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley
12/10/20 Credit Suisse
CureVac downgraded to Underperform on rising valuation at Credit Suisse
VXRT Vaxart
$6.60 /

-0.765 (-10.39%)

03/04/21 B. Riley
Vaxart price target lowered to $13 from $16 at B. Riley Securities
11/18/20 B. Riley
Vaxart price target lowered to $16 from $22 at B. Riley Securities
10/13/20 B. Riley
B. Riley views Vaxart as key player in 'second wave' of Covid vaccines
09/09/20 B. Riley
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
VXRT Vaxart
$6.60 /

-0.765 (-10.39%)

PFE Pfizer
$38.89 /

-0.69 (-1.74%)

NVAX Novavax
$168.55 /

-3.43 (-1.99%)

MRNA Moderna
$156.69 /

-5.99 (-3.68%)

JNJ Johnson & Johnson
$166.87 /

-0.22 (-0.13%)

AZN AstraZeneca
$53.16 /

-0.46 (-0.86%)

  • 28
    Jan
  • 14
    Aug
  • 23
    Jul
  • 19
    May
PFE Pfizer
$38.89 /

-0.69 (-1.74%)

NVAX Novavax
$168.55 /

-3.43 (-1.99%)

MRNA Moderna
$156.69 /

-5.99 (-3.68%)

JNJ Johnson & Johnson
$166.87 /

-0.22 (-0.13%)

CVAC CureVac
$93.30 /

-7.72 (-7.64%)

AZN AstraZeneca
$53.16 /

-0.46 (-0.86%)

VXRT Vaxart
$6.60 /

-0.765 (-10.39%)

PFE Pfizer
$38.89 /

-0.69 (-1.74%)

NVAX Novavax
$168.55 /

-3.43 (-1.99%)

MRNA Moderna
$156.69 /

-5.99 (-3.68%)

JNJ Johnson & Johnson
$166.87 /

-0.22 (-0.13%)

CVAC CureVac
$93.30 /

-7.72 (-7.64%)

BNTX BioNTech
$164.18 /

-6.5 (-3.81%)

AZN AstraZeneca
$53.16 /

-0.46 (-0.86%)

VXRT Vaxart
$6.60 /

-0.765 (-10.39%)

PFE Pfizer
$38.89 /

-0.69 (-1.74%)

NVAX Novavax
$168.55 /

-3.43 (-1.99%)

MRNA Moderna
$156.69 /

-5.99 (-3.68%)

JNJ Johnson & Johnson
$166.87 /

-0.22 (-0.13%)

CVAC CureVac
$93.30 /

-7.72 (-7.64%)

BNTX BioNTech
$164.18 /

-6.5 (-3.81%)

AZN AstraZeneca
$53.16 /

-0.46 (-0.86%)

Periodicals
Merkel opposes plan to waive COVID vaccine patent protection, Bloomberg says » 11:25
05/06/21
05/06
11:25
05/06/21
11:25
MRNA

Moderna

$148.75 /

-13.93 (-8.56%)

, PFE

Pfizer

$38.52 /

-1.06 (-2.68%)

, BNTX

BioNTech

$159.00 /

-11.68 (-6.84%)

, AZN

AstraZeneca

$53.02 /

-0.6 (-1.12%)

, JNJ

Johnson & Johnson

$166.44 /

-0.65 (-0.39%)

, NVAX

Novavax

$163.78 /

-8.2 (-4.77%)

, CVAC

CureVac

$90.08 /

-10.94 (-10.83%)

, VXRT

Vaxart

$6.41 /

-0.955 (-12.97%)

Bloomberg cites a German…

Bloomberg cites a German government spokesperson as saying that the U.S. plan would create "severe complications" for the production of vaccines. Companies with approved COVID-19 vaccines or working on such vaccines include Pfizer (PFE), BioNTech (BNTX), Moderna (MRNA), AstraZeneca (AZN), Johnson & Johnson (JNJ), Novavax (NVAX), Vaxart (VXRT) and CureVac (CVAC).

ShowHide Related Items >><<
VXRT Vaxart
$6.41 /

-0.955 (-12.97%)

PFE Pfizer
$38.52 /

-1.06 (-2.68%)

NVAX Novavax
$163.78 /

-8.2 (-4.77%)

MRNA Moderna
$148.75 /

-13.93 (-8.56%)

JNJ Johnson & Johnson
$166.44 /

-0.65 (-0.39%)

CVAC CureVac
$90.08 /

-10.94 (-10.83%)

BNTX BioNTech
$159.00 /

-11.68 (-6.84%)

AZN AstraZeneca
$53.02 /

-0.6 (-1.12%)

MRNA Moderna
$148.75 /

-13.93 (-8.56%)

05/05/21 Jefferies
Jefferies says COVID vaccine availability a supply-chain issue
05/03/21 Piper Sandler
Piper reiterates $234 target on Moderna after WHO Emergency Use Listing
04/29/21 Piper Sandler
Piper keeps $234 target on Moderna after raised Covid vaccine guidance
04/15/21 Piper Sandler
Moderna price target raised to $234 from $208 at Piper Sandler
PFE Pfizer
$38.52 /

-1.06 (-2.68%)

05/06/21
Fly Intel: Top five analyst downgrades
05/06/21 Mizuho
Pfizer downgraded to Neutral from Buy at Mizuho
05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
05/05/21 Barclays
Pfizer price target raised to $40 from $37 at Barclays
BNTX BioNTech
$159.00 /

-11.68 (-6.84%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
AZN AstraZeneca
$53.02 /

-0.6 (-1.12%)

05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/12/21
Fly Intel: Top five analyst downgrades
JNJ Johnson & Johnson
$166.44 /

-0.65 (-0.39%)

05/05/21 Argus
Emergent BioSolutions downgraded to Hold from Buy at Argus
04/29/21 Wells Fargo
Boston Scientific price target raised to $50 from $42 at Wells Fargo
04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
NVAX Novavax
$163.78 /

-8.2 (-4.77%)

03/26/21 B. Riley
Novavax selloff on 'rumored' production delay overdone, says B. Riley
03/12/21 H.C. Wainwright
Novavax price target raised to $317 from $207 at H.C. Wainwright
CVAC CureVac
$90.08 /

-10.94 (-10.83%)

04/26/21 Credit Suisse
CureVac assumed with an Underperform at Credit Suisse
04/26/21 Guggenheim
CureVac initiated with a Buy at Guggenheim
01/07/21 Morgan Stanley
CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley
12/10/20 Credit Suisse
CureVac downgraded to Underperform on rising valuation at Credit Suisse
VXRT Vaxart
$6.41 /

-0.955 (-12.97%)

03/04/21 B. Riley
Vaxart price target lowered to $13 from $16 at B. Riley Securities
11/18/20 B. Riley
Vaxart price target lowered to $16 from $22 at B. Riley Securities
10/13/20 B. Riley
B. Riley views Vaxart as key player in 'second wave' of Covid vaccines
09/09/20 B. Riley
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
VXRT Vaxart
$6.41 /

-0.955 (-12.97%)

PFE Pfizer
$38.52 /

-1.06 (-2.68%)

NVAX Novavax
$163.78 /

-8.2 (-4.77%)

MRNA Moderna
$148.75 /

-13.93 (-8.56%)

JNJ Johnson & Johnson
$166.44 /

-0.65 (-0.39%)

AZN AstraZeneca
$53.02 /

-0.6 (-1.12%)

  • 28
    Jan
  • 14
    Aug
  • 23
    Jul
  • 19
    May
PFE Pfizer
$38.52 /

-1.06 (-2.68%)

NVAX Novavax
$163.78 /

-8.2 (-4.77%)

MRNA Moderna
$148.75 /

-13.93 (-8.56%)

JNJ Johnson & Johnson
$166.44 /

-0.65 (-0.39%)

CVAC CureVac
$90.08 /

-10.94 (-10.83%)

AZN AstraZeneca
$53.02 /

-0.6 (-1.12%)

VXRT Vaxart
$6.41 /

-0.955 (-12.97%)

PFE Pfizer
$38.52 /

-1.06 (-2.68%)

NVAX Novavax
$163.78 /

-8.2 (-4.77%)

MRNA Moderna
$148.75 /

-13.93 (-8.56%)

JNJ Johnson & Johnson
$166.44 /

-0.65 (-0.39%)

CVAC CureVac
$90.08 /

-10.94 (-10.83%)

BNTX BioNTech
$159.00 /

-11.68 (-6.84%)

AZN AstraZeneca
$53.02 /

-0.6 (-1.12%)

VXRT Vaxart
$6.41 /

-0.955 (-12.97%)

PFE Pfizer
$38.52 /

-1.06 (-2.68%)

NVAX Novavax
$163.78 /

-8.2 (-4.77%)

MRNA Moderna
$148.75 /

-13.93 (-8.56%)

JNJ Johnson & Johnson
$166.44 /

-0.65 (-0.39%)

CVAC CureVac
$90.08 /

-10.94 (-10.83%)

BNTX BioNTech
$159.00 /

-11.68 (-6.84%)

AZN AstraZeneca
$53.02 /

-0.6 (-1.12%)

Hot Stocks
Pfizer, BioNTech to provide COVID vaccine doses at 2020 Tokyo Games » 06:34
05/06/21
05/06
06:34
05/06/21
06:34
PFE

Pfizer

$39.58 /

-0.39 (-0.98%)

, BNTX

BioNTech

$170.68 /

-6.22 (-3.52%)

Pfizer (PFE) and BioNTech…

Pfizer (PFE) and BioNTech (BNTX) announced the signing of a Memorandum of Understanding with the International Olympic Committee to donate doses of the companies' COVID-19 Vaccine to help vaccinate athletes, and their delegations, participating in the Olympic and Paralympic Games Tokyo 2020, which are scheduled to begin on July 23, 2021. Under the MoU, the companies and the IOC will coordinate with National Olympic Committees around the world to understand and work to help address the local need for vaccine doses for national delegations' participation in the Games. Delivery of initial doses to participating delegations is expected to begin at the end of May where possible with the aim to ensure participating delegations receive second doses ahead of arrivals in Tokyo. Under the MoU framework, NOCs and their local governments are expected to coordinate the administration of vaccinations to eligible Games participants. Doses provided under this MoU would be in addition to doses provided under supply agreements with governments worldwide. The donation of vaccine doses will not affect the supply of the national populations with COVID-19 doses under the supply agreements.

ShowHide Related Items >><<
PFE Pfizer
$39.58 /

-0.39 (-0.98%)

BNTX BioNTech
$170.68 /

-6.22 (-3.52%)

PFE Pfizer
$39.58 /

-0.39 (-0.98%)

05/06/21 Mizuho
Pfizer downgraded to Neutral from Buy at Mizuho
05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
05/05/21 Barclays
Pfizer price target raised to $40 from $37 at Barclays
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
BNTX BioNTech
$170.68 /

-6.22 (-3.52%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
PFE Pfizer
$39.58 /

-0.39 (-0.98%)

  • 23
    Jul
PFE Pfizer
$39.58 /

-0.39 (-0.98%)

PFE Pfizer
$39.58 /

-0.39 (-0.98%)

PFE Pfizer
$39.58 /

-0.39 (-0.98%)

BNTX BioNTech
$170.68 /

-6.22 (-3.52%)

Wednesday
On The Fly
Fly Intel: Wall Street's top stories for Wednesday » 17:23
05/05/21
05/05
17:23
05/05/21
17:23
GM

General Motors

$57.56 /

+2.215 (+4.00%)

, LYFT

Lyft

$52.61 /

-3.56 (-6.34%)

, TMUS

T-Mobile

$134.14 /

+5.43 (+4.22%)

, FB

Facebook

$315.06 /

-3.54 (-1.11%)

, PTON

Peloton

$82.61 /

-14.26 (-14.72%)

, HNST

Honest Company

$22.95 /

+1.65 (+7.75%)

, PFE

Pfizer

$39.97 /

+ (+0.00%)

, BNTX

BioNTech

$170.68 /

-6.22 (-3.52%)

, GME

GameStop

$159.40 /

-1.6 (-0.99%)

, ATNX

Athenex

$4.57 /

+0.85 (+22.85%)

, HAYW

Hayward

$24.15 /

+4.755 (+24.52%)

, HFC

HollyFrontier

$34.69 /

-1.57 (-4.33%)

, ESPR

Esperion

$20.01 /

-5.585 (-21.82%)

, RDS.A

Royal Dutch Shell

$39.80 /

+1.16 (+3.00%)

, RDS.B

Royal Dutch Shell

$37.47 /

+1.26 (+3.48%)

, MRNA

Moderna

$162.64 /

-11.025 (-6.35%)

, JNJ

Johnson & Johnson

$167.09 /

-0.67 (-0.40%)

The major averages were…

ShowHide Related Items >><<
TMUS T-Mobile
$134.14 /

+5.43 (+4.22%)

RDS.B Royal Dutch Shell
$37.47 /

+1.26 (+3.48%)

RDS.A Royal Dutch Shell
$39.80 /

+1.16 (+3.00%)

PTON Peloton
$82.61 /

-14.26 (-14.72%)

PFE Pfizer
$39.97 /

+ (+0.00%)

MRNA Moderna
$162.64 /

-11.025 (-6.35%)

LYFT Lyft
$52.61 /

-3.56 (-6.34%)

JNJ Johnson & Johnson
$167.09 /

-0.67 (-0.40%)

HFC HollyFrontier
$34.69 /

-1.57 (-4.33%)

HAYW Hayward
$24.15 /

+4.755 (+24.52%)

GME GameStop
$159.40 /

-1.6 (-0.99%)

GM General Motors
$57.56 /

+2.215 (+4.00%)

FB Facebook
$315.06 /

-3.54 (-1.11%)

ESPR Esperion
$20.01 /

-5.585 (-21.82%)

BNTX BioNTech
$170.68 /

-6.22 (-3.52%)

ATNX Athenex
$4.57 /

+0.85 (+22.85%)

GM General Motors
$57.56 /

+2.215 (+4.00%)

05/06/21 Deutsche Bank
General Motors price target raised to $70 from $67 at Deutsche Bank
05/06/21 RBC Capital
General Motors price target raised to $72 from $67 at RBC Capital
05/06/21 Barclays
General Motors price target raised to $66 from $64 at Barclays
04/22/21 Wolfe Research
Wolfe upgrades Ford with $15 target, sees GM-like 'significant re-rating'
LYFT Lyft
$52.61 /

-3.56 (-6.34%)

05/06/21 Citi
Lyft price target raised to $80 from $76 at Citi
05/06/21 Piper Sandler
Uber price target lowered to $55 from $58 at Piper Sandler
05/05/21 Cowen
Department of Labor comments incrementally encouraging for Uber/Lyft, says Cowen
05/05/21 DA Davidson
Lyft price target raised to $72 from $66 at DA Davidson
TMUS T-Mobile
$134.14 /

+5.43 (+4.22%)

04/26/21 Oppenheimer
Crown Castle price target raised to $205 from $170 at Oppenheimer
04/19/21 Deutsche Bank
T-Mobile price target raised to $185 from $155 at Deutsche Bank
03/30/21 KeyBanc
KeyBanc sees partnership with Google as neutral to T-Mobile
03/12/21 Morgan Stanley
T-Mobile highlighted 'impressive' cash flow ramp at event, says Morgan Stanley
FB Facebook
$315.06 /

-3.54 (-1.11%)

04/29/21 KeyBanc
Facebook price target raised to $414 from $360 at KeyBanc
04/29/21 Truist
Facebook price target raised to $400 from $350 at Truist
04/29/21 Wedbush
Facebook price target raised to $355 from $340 at Wedbush
04/29/21 Canaccord
Facebook price target raised to $380 from $350 at Canaccord
PTON Peloton
$82.61 /

-14.26 (-14.72%)

05/05/21 BofA
Peloton downgraded to Neutral after 'thesis changing' recalls at BofA
05/05/21 BofA
Peloton downgraded to Neutral from Buy at BofA
05/05/21 BMO Capital
BMO Capital continues to worry Peloton shares will catch down to fundamentals
05/05/21 JPMorgan
JPMorgan sees Peloton shares remaining under pressure
HNST Honest Company
$22.95 /

+1.65 (+7.75%)

PFE Pfizer
$39.97 /

+ (+0.00%)

05/06/21 Mizuho
Pfizer downgraded to Neutral from Buy at Mizuho
05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
05/05/21 Barclays
Pfizer price target raised to $40 from $37 at Barclays
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
BNTX BioNTech
$170.68 /

-6.22 (-3.52%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
GME GameStop
$159.40 /

-1.6 (-0.99%)

04/12/21
Fly Intel: Top five analyst downgrades
04/12/21 Ascendiant
GameStop downgraded to Sell from Hold at Ascendiant
04/06/21 BofA
BofA keeps $10 target on GameStop despite 'positive' funding news
04/05/21 Telsey Advisory
Telsey keeps Underperform rating on GameStop after Q1 update, ATM program bump
ATNX Athenex
$4.57 /

+0.85 (+22.85%)

03/02/21
Fly Intel: Top five analyst downgrades
03/02/21 SVB Leerink
Athenex downgraded to Market Perform from Outperform at SVB Leerink
03/02/21 Oppenheimer
Athenex downgraded to Perform from Outperform at Oppenheimer
03/02/21 Truist
Athenex downgraded to Hold from Buy at Truist
HAYW Hayward
$24.15 /

+4.755 (+24.52%)

05/06/21 KeyBanc
Hayward price target raised to $28 from $21 at KeyBanc
05/06/21 Morgan Stanley
Hayward price target raised to $27 from $19 at Morgan Stanley
05/06/21 Baird
Hayward price target raised to $28 from $20 at Baird
04/06/21 Jefferies
Hayward initiated with a Buy at Jefferies
HFC HollyFrontier
$34.69 /

-1.57 (-4.33%)

04/01/21 Piper Sandler
HollyFrontier price target raised to $45 from $35 at Piper Sandler
03/17/21 US Capital Advisors
HollyFrontier downgraded to Hold from Overweight at US Capital Advisors
03/08/21 Barclays
HollyFrontier price target raised to $38 from $35 at Barclays
02/26/21 Mizuho
HollyFrontier price target raised to $40 from $25 at Mizuho
ESPR Esperion
$20.01 /

-5.585 (-21.82%)

05/05/21 BTIG
Esperion price target lowered to $71 from $90 at BTIG
05/05/21 Northland
Esperion price target lowered to $24 from $30 at Northland
05/05/21 Credit Suisse
Esperion price target lowered to $36 from $45 at Credit Suisse
05/05/21 Stifel
Stifel downgrades Esperion to Hold with bull case seen 'off the table'
RDS.A Royal Dutch Shell
$39.80 /

+1.16 (+3.00%)

04/30/21 Credit Suisse
Royal Dutch Shell price target raised to 1,860 GBp at Credit Suisse
04/20/21 Deutsche Bank
Royal Dutch Shell initiated with a Buy at Deutsche Bank
04/08/21 Barclays
Royal Dutch Shell price target raised to 1,700 GBp from 1,500 GBp at Barclays
04/01/21 Piper Sandler
Royal Dutch Shell price target raised to $55 from $48 at Piper Sandler
RDS.B Royal Dutch Shell
$37.47 /

+1.26 (+3.48%)

03/12/21 Societe Generale
Royal Dutch Shell upgraded to Buy from Hold at Societe Generale
03/03/21 JPMorgan
Royal Dutch Shell price target raised to 2,000 GBp from 1,700 GBp at JPMorgan
02/12/21 Scotiabank
Royal Dutch Shell upgraded to Sector Perform from Underperform at Scotiabank
MRNA Moderna
$162.64 /

-11.025 (-6.35%)

05/05/21 Jefferies
Jefferies says COVID vaccine availability a supply-chain issue
05/03/21 Piper Sandler
Piper reiterates $234 target on Moderna after WHO Emergency Use Listing
04/29/21 Piper Sandler
Piper keeps $234 target on Moderna after raised Covid vaccine guidance
04/15/21 Piper Sandler
Moderna price target raised to $234 from $208 at Piper Sandler
JNJ Johnson & Johnson
$167.09 /

-0.67 (-0.40%)

05/05/21 Argus
Emergent BioSolutions downgraded to Hold from Buy at Argus
04/29/21 Wells Fargo
Boston Scientific price target raised to $50 from $42 at Wells Fargo
04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
TMUS T-Mobile
$134.14 /

+5.43 (+4.22%)

RDS.A Royal Dutch Shell
$39.80 /

+1.16 (+3.00%)

PTON Peloton
$82.61 /

-14.26 (-14.72%)

PFE Pfizer
$39.97 /

+ (+0.00%)

MRNA Moderna
$162.64 /

-11.025 (-6.35%)

LYFT Lyft
$52.61 /

-3.56 (-6.34%)

JNJ Johnson & Johnson
$167.09 /

-0.67 (-0.40%)

HFC HollyFrontier
$34.69 /

-1.57 (-4.33%)

HAYW Hayward
$24.15 /

+4.755 (+24.52%)

GME GameStop
$159.40 /

-1.6 (-0.99%)

GM General Motors
$57.56 /

+2.215 (+4.00%)

FB Facebook
$315.06 /

-3.54 (-1.11%)

ESPR Esperion
$20.01 /

-5.585 (-21.82%)

ATNX Athenex
$4.57 /

+0.85 (+22.85%)

  • 05
    May
  • 12
    Mar
  • 10
    Sep
  • 23
    Jul
  • 24
    Jun
  • 19
    May
TMUS T-Mobile
$134.14 /

+5.43 (+4.22%)

RDS.B Royal Dutch Shell
$37.47 /

+1.26 (+3.48%)

RDS.A Royal Dutch Shell
$39.80 /

+1.16 (+3.00%)

PTON Peloton
$82.61 /

-14.26 (-14.72%)

PFE Pfizer
$39.97 /

+ (+0.00%)

MRNA Moderna
$162.64 /

-11.025 (-6.35%)

LYFT Lyft
$52.61 /

-3.56 (-6.34%)

JNJ Johnson & Johnson
$167.09 /

-0.67 (-0.40%)

HNST Honest Company
$22.95 /

+1.65 (+7.75%)

HFC HollyFrontier
$34.69 /

-1.57 (-4.33%)

GME GameStop
$159.40 /

-1.6 (-0.99%)

GM General Motors
$57.56 /

+2.215 (+4.00%)

FB Facebook
$315.06 /

-3.54 (-1.11%)

TMUS T-Mobile
$134.14 /

+5.43 (+4.22%)

PTON Peloton
$82.61 /

-14.26 (-14.72%)

PFE Pfizer
$39.97 /

+ (+0.00%)

MRNA Moderna
$162.64 /

-11.025 (-6.35%)

LYFT Lyft
$52.61 /

-3.56 (-6.34%)

JNJ Johnson & Johnson
$167.09 /

-0.67 (-0.40%)

HAYW Hayward
$24.15 /

+4.755 (+24.52%)

GME GameStop
$159.40 /

-1.6 (-0.99%)

GM General Motors
$57.56 /

+2.215 (+4.00%)

FB Facebook
$315.06 /

-3.54 (-1.11%)

ESPR Esperion
$20.01 /

-5.585 (-21.82%)

ATNX Athenex
$4.57 /

+0.85 (+22.85%)

TMUS T-Mobile
$134.14 /

+5.43 (+4.22%)

PTON Peloton
$82.61 /

-14.26 (-14.72%)

PFE Pfizer
$39.97 /

+ (+0.00%)

MRNA Moderna
$162.64 /

-11.025 (-6.35%)

LYFT Lyft
$52.61 /

-3.56 (-6.34%)

JNJ Johnson & Johnson
$167.09 /

-0.67 (-0.40%)

HFC HollyFrontier
$34.69 /

-1.57 (-4.33%)

HAYW Hayward
$24.15 /

+4.755 (+24.52%)

GME GameStop
$159.40 /

-1.6 (-0.99%)

GM General Motors
$57.56 /

+2.215 (+4.00%)

FB Facebook
$315.06 /

-3.54 (-1.11%)

BNTX BioNTech
$170.68 /

-6.22 (-3.52%)

Periodicals
Trade Representative tells Bloomberg U.S. to back vaccine IP protections waiver » 15:27
05/05/21
05/05
15:27
05/05/21
15:27
PFE

Pfizer

$39.34 /

-0.63 (-1.58%)

, MRNA

Moderna

$160.71 /

-12.95 (-7.46%)

, NVAX

Novavax

$176.44 /

-4.93 (-2.72%)

, BNTX

BioNTech

$172.15 /

-4.75 (-2.69%)

The U.S. will support a…

The U.S. will support a proposal to waive intellectual-property protections for COVID-19 vaccines, joining an effort to increase global supply and access to the life-saving shots as the gap between rich and poor nations widens, Bloomberg's Jenny Leonard and Eric Martin report. "We are for the waiver at the WTO, we are for what the proponents of the waiver are trying to accomplish, which is better access, more manufacturing capability, more shots in arms," U.S. Trade Representative Katherine Tai said in an interview with Bloomberg. In afternoon trading, some COVID vaccine makers are trading lower, with Pfizer (PFE) slipping about 1%, Moderna (MRNA) sliding over 5%, Novavax (NVAX) dropping almost 8% and BioNTech (BNTX) sliding over 3%. Reference Link

ShowHide Related Items >><<
PFE Pfizer
$39.34 /

-0.63 (-1.58%)

NVAX Novavax
$176.44 /

-4.93 (-2.72%)

MRNA Moderna
$160.71 /

-12.95 (-7.46%)

BNTX BioNTech
$172.15 /

-4.75 (-2.69%)

PFE Pfizer
$39.34 /

-0.63 (-1.58%)

05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
05/05/21 Barclays
Pfizer price target raised to $40 from $37 at Barclays
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
MRNA Moderna
$160.71 /

-12.95 (-7.46%)

05/03/21 Piper Sandler
Piper reiterates $234 target on Moderna after WHO Emergency Use Listing
04/29/21 Piper Sandler
Piper keeps $234 target on Moderna after raised Covid vaccine guidance
04/15/21 Piper Sandler
Moderna price target raised to $234 from $208 at Piper Sandler
NVAX Novavax
$176.44 /

-4.93 (-2.72%)

04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
03/26/21 B. Riley
Novavax selloff on 'rumored' production delay overdone, says B. Riley
03/12/21 H.C. Wainwright
Novavax price target raised to $317 from $207 at H.C. Wainwright
02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
BNTX BioNTech
$172.15 /

-4.75 (-2.69%)

02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
PFE Pfizer
$39.34 /

-0.63 (-1.58%)

NVAX Novavax
$176.44 /

-4.93 (-2.72%)

MRNA Moderna
$160.71 /

-12.95 (-7.46%)

  • 23
    Jul
  • 19
    May
PFE Pfizer
$39.34 /

-0.63 (-1.58%)

NVAX Novavax
$176.44 /

-4.93 (-2.72%)

MRNA Moderna
$160.71 /

-12.95 (-7.46%)

BNTX BioNTech
$172.15 /

-4.75 (-2.69%)

PFE Pfizer
$39.34 /

-0.63 (-1.58%)

NVAX Novavax
$176.44 /

-4.93 (-2.72%)

MRNA Moderna
$160.71 /

-12.95 (-7.46%)

PFE Pfizer
$39.34 /

-0.63 (-1.58%)

NVAX Novavax
$176.44 /

-4.93 (-2.72%)

MRNA Moderna
$160.71 /

-12.95 (-7.46%)

BNTX BioNTech
$172.15 /

-4.75 (-2.69%)

Periodicals
U.S. supports waiver of vaccine-patent protections at WTO, Bloomberg reports » 15:01
05/05/21
05/05
15:01
05/05/21
15:01
PFE

Pfizer

$40.60 /

+0.63 (+1.58%)

, BNTX

BioNTech

$188.50 /

+11.6 (+6.56%)

, MRNA

Moderna

$177.76 /

+4.1 (+2.36%)

, AZN

AstraZeneca

$53.52 /

+0.565 (+1.07%)

, JNJ

Johnson & Johnson

$167.34 /

-0.42 (-0.25%)

, NVAX

Novavax

$190.79 /

+9.42 (+5.19%)

Bloomberg cites comments…

Bloomberg cites comments made in an interview by U.S. Trade Representative Katherine Tai. Companies with approved COVID-19 vaccines or working on such vaccines include Pfizer (PFE), Moderna (MRNA), AstraZeneca (AZN), Johnson & Johnson (JNJ) and Novavax (NVAX).

ShowHide Related Items >><<
PFE Pfizer
$40.60 /

+0.63 (+1.58%)

NVAX Novavax
$190.79 /

+9.42 (+5.19%)

MRNA Moderna
$177.76 /

+4.1 (+2.36%)

JNJ Johnson & Johnson
$167.34 /

-0.42 (-0.25%)

BNTX BioNTech
$188.50 /

+11.6 (+6.56%)

AZN AstraZeneca
$53.52 /

+0.565 (+1.07%)

PFE Pfizer
$40.60 /

+0.63 (+1.58%)

05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
05/05/21 Barclays
Pfizer price target raised to $40 from $37 at Barclays
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
BNTX BioNTech
$188.50 /

+11.6 (+6.56%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
MRNA Moderna
$177.76 /

+4.1 (+2.36%)

05/03/21 Piper Sandler
Piper reiterates $234 target on Moderna after WHO Emergency Use Listing
04/29/21 Piper Sandler
Piper keeps $234 target on Moderna after raised Covid vaccine guidance
04/15/21 Piper Sandler
Moderna price target raised to $234 from $208 at Piper Sandler
AZN AstraZeneca
$53.52 /

+0.565 (+1.07%)

05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/12/21
Fly Intel: Top five analyst downgrades
JNJ Johnson & Johnson
$167.34 /

-0.42 (-0.25%)

05/05/21 Argus
Emergent BioSolutions downgraded to Hold from Buy at Argus
04/29/21 Wells Fargo
Boston Scientific price target raised to $50 from $42 at Wells Fargo
04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
NVAX Novavax
$190.79 /

+9.42 (+5.19%)

03/26/21 B. Riley
Novavax selloff on 'rumored' production delay overdone, says B. Riley
03/12/21 H.C. Wainwright
Novavax price target raised to $317 from $207 at H.C. Wainwright
PFE Pfizer
$40.60 /

+0.63 (+1.58%)

NVAX Novavax
$190.79 /

+9.42 (+5.19%)

MRNA Moderna
$177.76 /

+4.1 (+2.36%)

JNJ Johnson & Johnson
$167.34 /

-0.42 (-0.25%)

AZN AstraZeneca
$53.52 /

+0.565 (+1.07%)

  • 23
    Jul
  • 19
    May
PFE Pfizer
$40.60 /

+0.63 (+1.58%)

NVAX Novavax
$190.79 /

+9.42 (+5.19%)

MRNA Moderna
$177.76 /

+4.1 (+2.36%)

JNJ Johnson & Johnson
$167.34 /

-0.42 (-0.25%)

BNTX BioNTech
$188.50 /

+11.6 (+6.56%)

AZN AstraZeneca
$53.52 /

+0.565 (+1.07%)

PFE Pfizer
$40.60 /

+0.63 (+1.58%)

NVAX Novavax
$190.79 /

+9.42 (+5.19%)

MRNA Moderna
$177.76 /

+4.1 (+2.36%)

JNJ Johnson & Johnson
$167.34 /

-0.42 (-0.25%)

BNTX BioNTech
$188.50 /

+11.6 (+6.56%)

AZN AstraZeneca
$53.52 /

+0.565 (+1.07%)

PFE Pfizer
$40.60 /

+0.63 (+1.58%)

NVAX Novavax
$190.79 /

+9.42 (+5.19%)

MRNA Moderna
$177.76 /

+4.1 (+2.36%)

JNJ Johnson & Johnson
$167.34 /

-0.42 (-0.25%)

BNTX BioNTech
$188.50 /

+11.6 (+6.56%)

AZN AstraZeneca
$53.52 /

+0.565 (+1.07%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:35
05/05/21
05/05
12:35
05/05/21
12:35
GM

General Motors

$57.72 /

+2.38 (+4.30%)

, LYFT

Lyft

$54.03 /

-2.14 (-3.81%)

, PTON

Peloton

$85.35 /

-11.52 (-11.89%)

, HNST

Honest Company

$23.00 /

+1.7 (+7.98%)

, PFE

Pfizer

$40.84 /

+0.865 (+2.16%)

, BNTX

BioNTech

$193.73 /

+16.83 (+9.51%)

, TMUS

T-Mobile

$134.60 /

+5.89 (+4.58%)

, FB

Facebook

$319.01 /

+0.405 (+0.13%)

, ATNX

Athenex

$5.22 /

+1.5 (+40.32%)

, VERU

Veru

$8.76 /

+0.04 (+0.46%)

, ESPR

Esperion

$19.40 /

-6.19 (-24.19%)

, HFC

HollyFrontier

$33.72 /

-2.54 (-7.00%)

, RDS.A

Royal Dutch Shell

$39.75 /

+1.11 (+2.87%)

, RDS.B

Royal Dutch Shell

$37.42 /

+1.21 (+3.34%)

The major averages are…

ShowHide Related Items >><<
VERU Veru
$8.76 /

+0.04 (+0.46%)

TMUS T-Mobile
$134.60 /

+5.89 (+4.58%)

RDS.B Royal Dutch Shell
$37.42 /

+1.21 (+3.34%)

RDS.A Royal Dutch Shell
$39.75 /

+1.11 (+2.87%)

PTON Peloton
$85.35 /

-11.52 (-11.89%)

PFE Pfizer
$40.84 /

+0.865 (+2.16%)

LYFT Lyft
$54.03 /

-2.14 (-3.81%)

HFC HollyFrontier
$33.72 /

-2.54 (-7.00%)

GM General Motors
$57.72 /

+2.38 (+4.30%)

FB Facebook
$319.01 /

+0.405 (+0.13%)

ESPR Esperion
$19.40 /

-6.19 (-24.19%)

BNTX BioNTech
$193.73 /

+16.83 (+9.51%)

ATNX Athenex
$5.22 /

+1.5 (+40.32%)

GM General Motors
$57.72 /

+2.38 (+4.30%)

04/22/21 Wolfe Research
Wolfe upgrades Ford with $15 target, sees GM-like 'significant re-rating'
04/20/21 BofA
Lordstown Motors initiated with a Neutral at BofA
04/14/21 Evercore ISI
General Motors price target raised to $65 from $62 at Evercore ISI
04/05/21
Fly Intel: Top five analyst initiations
LYFT Lyft
$54.03 /

-2.14 (-3.81%)

05/05/21 DA Davidson
Lyft price target raised to $72 from $66 at DA Davidson
05/05/21 Susquehanna
Lyft ridesharing recovery taking place, says Susquehanna
05/05/21 Morgan Stanley
Lyft price target raised to $70 from $65 at Morgan Stanley
05/05/21 Stifel
Lyft price target raised to $60 from $55 at Stifel
PTON Peloton
$85.35 /

-11.52 (-11.89%)

05/05/21 Truist
Peloton recall likely to result in one time financial costs, says Truist
05/05/21 KeyBanc
Peloton Tread, Tread+ recalls a 'clear negative,' says KeyBanc
04/19/21 JPMorgan
Peloton should be bought on pullback from safety warning, says JPMorgan
04/19/21 Truist
CSPC warning unlikely to have material impact on Peloton P&L, saysTruist
HNST Honest Company
$23.00 /

+1.7 (+7.98%)

PFE Pfizer
$40.84 /

+0.865 (+2.16%)

05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
05/05/21 Barclays
Pfizer price target raised to $40 from $37 at Barclays
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
BNTX BioNTech
$193.73 /

+16.83 (+9.51%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
TMUS T-Mobile
$134.60 /

+5.89 (+4.58%)

04/26/21 Oppenheimer
Crown Castle price target raised to $205 from $170 at Oppenheimer
04/19/21 Deutsche Bank
T-Mobile price target raised to $185 from $155 at Deutsche Bank
03/30/21 KeyBanc
KeyBanc sees partnership with Google as neutral to T-Mobile
03/12/21 Morgan Stanley
T-Mobile highlighted 'impressive' cash flow ramp at event, says Morgan Stanley
FB Facebook
$319.01 /

+0.405 (+0.13%)

04/29/21 KeyBanc
Facebook price target raised to $414 from $360 at KeyBanc
04/29/21 Truist
Facebook price target raised to $400 from $350 at Truist
04/29/21 Wedbush
Facebook price target raised to $355 from $340 at Wedbush
04/29/21 Canaccord
Facebook price target raised to $380 from $350 at Canaccord
ATNX Athenex
$5.22 /

+1.5 (+40.32%)

03/02/21
Fly Intel: Top five analyst downgrades
03/02/21 SVB Leerink
Athenex downgraded to Market Perform from Outperform at SVB Leerink
03/02/21 Oppenheimer
Athenex downgraded to Perform from Outperform at Oppenheimer
03/02/21 Truist
Athenex downgraded to Hold from Buy at Truist
VERU Veru
$8.76 /

+0.04 (+0.46%)

04/13/21 Jefferies
Veru initiated with a Buy at Jefferies
02/11/21 Oppenheimer
Veru price target raised to $24 from $19 at Oppenheimer
02/11/21 H.C. Wainwright
Veru price target raised to $22 from $17 at H.C. Wainwright
02/09/21 H.C. Wainwright
Veru price target raised to $17 from $12 at H.C. Wainwright
ESPR Esperion
$19.40 /

-6.19 (-24.19%)

05/05/21 BTIG
Esperion price target lowered to $71 from $90 at BTIG
05/05/21 Northland
Esperion price target lowered to $24 from $30 at Northland
05/05/21 Credit Suisse
Esperion price target lowered to $36 from $45 at Credit Suisse
05/05/21 Stifel
Stifel downgrades Esperion to Hold with bull case seen 'off the table'
HFC HollyFrontier
$33.72 /

-2.54 (-7.00%)

04/01/21 Piper Sandler
HollyFrontier price target raised to $45 from $35 at Piper Sandler
03/17/21 US Capital Advisors
HollyFrontier downgraded to Hold from Overweight at US Capital Advisors
03/08/21 Barclays
HollyFrontier price target raised to $38 from $35 at Barclays
02/26/21 Mizuho
HollyFrontier price target raised to $40 from $25 at Mizuho
RDS.A Royal Dutch Shell
$39.75 /

+1.11 (+2.87%)

04/30/21 Credit Suisse
Royal Dutch Shell price target raised to 1,860 GBp at Credit Suisse
04/20/21 Deutsche Bank
Royal Dutch Shell initiated with a Buy at Deutsche Bank
04/08/21 Barclays
Royal Dutch Shell price target raised to 1,700 GBp from 1,500 GBp at Barclays
04/01/21 Piper Sandler
Royal Dutch Shell price target raised to $55 from $48 at Piper Sandler
RDS.B Royal Dutch Shell
$37.42 /

+1.21 (+3.34%)

03/12/21 Societe Generale
Royal Dutch Shell upgraded to Buy from Hold at Societe Generale
03/03/21 JPMorgan
Royal Dutch Shell price target raised to 2,000 GBp from 1,700 GBp at JPMorgan
02/12/21 Scotiabank
Royal Dutch Shell upgraded to Sector Perform from Underperform at Scotiabank
VERU Veru
$8.76 /

+0.04 (+0.46%)

TMUS T-Mobile
$134.60 /

+5.89 (+4.58%)

RDS.A Royal Dutch Shell
$39.75 /

+1.11 (+2.87%)

PTON Peloton
$85.35 /

-11.52 (-11.89%)

PFE Pfizer
$40.84 /

+0.865 (+2.16%)

LYFT Lyft
$54.03 /

-2.14 (-3.81%)

HFC HollyFrontier
$33.72 /

-2.54 (-7.00%)

GM General Motors
$57.72 /

+2.38 (+4.30%)

FB Facebook
$319.01 /

+0.405 (+0.13%)

ESPR Esperion
$19.40 /

-6.19 (-24.19%)

ATNX Athenex
$5.22 /

+1.5 (+40.32%)

  • 05
    May
  • 18
    Feb
  • 10
    Sep
  • 23
    Jul
  • 24
    Jun
TMUS T-Mobile
$134.60 /

+5.89 (+4.58%)

RDS.B Royal Dutch Shell
$37.42 /

+1.21 (+3.34%)

RDS.A Royal Dutch Shell
$39.75 /

+1.11 (+2.87%)

PTON Peloton
$85.35 /

-11.52 (-11.89%)

PFE Pfizer
$40.84 /

+0.865 (+2.16%)

LYFT Lyft
$54.03 /

-2.14 (-3.81%)

HNST Honest Company
$23.00 /

+1.7 (+7.98%)

HFC HollyFrontier
$33.72 /

-2.54 (-7.00%)

GM General Motors
$57.72 /

+2.38 (+4.30%)

FB Facebook
$319.01 /

+0.405 (+0.13%)

BNTX BioNTech
$193.73 /

+16.83 (+9.51%)

VERU Veru
$8.76 /

+0.04 (+0.46%)

TMUS T-Mobile
$134.60 /

+5.89 (+4.58%)

PTON Peloton
$85.35 /

-11.52 (-11.89%)

PFE Pfizer
$40.84 /

+0.865 (+2.16%)

LYFT Lyft
$54.03 /

-2.14 (-3.81%)

GM General Motors
$57.72 /

+2.38 (+4.30%)

FB Facebook
$319.01 /

+0.405 (+0.13%)

ESPR Esperion
$19.40 /

-6.19 (-24.19%)

BNTX BioNTech
$193.73 /

+16.83 (+9.51%)

ATNX Athenex
$5.22 /

+1.5 (+40.32%)

VERU Veru
$8.76 /

+0.04 (+0.46%)

TMUS T-Mobile
$134.60 /

+5.89 (+4.58%)

PTON Peloton
$85.35 /

-11.52 (-11.89%)

PFE Pfizer
$40.84 /

+0.865 (+2.16%)

LYFT Lyft
$54.03 /

-2.14 (-3.81%)

HFC HollyFrontier
$33.72 /

-2.54 (-7.00%)

GM General Motors
$57.72 /

+2.38 (+4.30%)

FB Facebook
$319.01 /

+0.405 (+0.13%)

BNTX BioNTech
$193.73 /

+16.83 (+9.51%)

Hot Stocks
CDC tells Bloomberg will meet on Pfizer COVID-19 shot for teens on May 12 » 10:46
05/05/21
05/05
10:46
05/05/21
10:46
PFE

Pfizer

$40.95 /

+0.9801 (+2.45%)

, BNTX

BioNTech

$190.87 /

+13.97 (+7.90%)

A CDC spokeswoman told…

A CDC spokeswoman told Bloomberg in an email that the CDC has scheduled an advisory committee meeting for May 12 to consider the use of the COVID-19 vaccine developed by Pfizer (PFE) and BioNTech (BNTX) to include individuals 12 to 15 years of age.

ShowHide Related Items >><<
PFE Pfizer
$40.95 /

+0.9801 (+2.45%)

BNTX BioNTech
$190.87 /

+13.97 (+7.90%)

PFE Pfizer
$40.95 /

+0.9801 (+2.45%)

05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
05/05/21 Barclays
Pfizer price target raised to $40 from $37 at Barclays
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
BNTX BioNTech
$190.87 /

+13.97 (+7.90%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
PFE Pfizer
$40.95 /

+0.9801 (+2.45%)

  • 23
    Jul
PFE Pfizer
$40.95 /

+0.9801 (+2.45%)

BNTX BioNTech
$190.87 /

+13.97 (+7.90%)

PFE Pfizer
$40.95 /

+0.9801 (+2.45%)

BNTX BioNTech
$190.87 /

+13.97 (+7.90%)

PFE Pfizer
$40.95 /

+0.9801 (+2.45%)

BNTX BioNTech
$190.87 /

+13.97 (+7.90%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.